Literature DB >> 26761542

Malignancies with Low Fluorodeoxyglucose Uptake at PET/CT: Pitfalls and Prognostic Importance: Resident and Fellow Education Feature.

Robert R Flavell1, David M Naeger1, Carina Mari Aparici1, Randall A Hawkins1, Miguel H Pampaloni1, Spencer C Behr1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26761542      PMCID： PMC4801421          DOI： 10.1148/rg.2016150073

Source DB:  PubMed          Journal:  Radiographics        ISSN： 0271-5333            Impact factor:   5.333


× No keyword cloud information.
  3 in total

1.  FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features.

Authors:  K L Berger; S A Nicholson; F Dehdashti; B A Siegel
Journal:  AJR Am J Roentgenol       Date:  2000-04       Impact factor: 3.959

2.  Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma.

Authors:  David E Kang; Richard L White; James H Zuger; Howell C Sasser; Chris M Teigland
Journal:  J Urol       Date:  2004-05       Impact factor: 7.450

3.  High prognostic value of 18F-FDG PET for metastatic gastroenteropancreatic neuroendocrine tumors: a long-term evaluation.

Authors:  Haïfa Bahri; Lenoir Laurence; Julien Edeline; Houda Leghzali; Anne Devillers; Jean-Luc Raoul; Marc Cuggia; Habiba Mesbah; Bruno Clement; Eveline Boucher; Etienne Garin
Journal:  J Nucl Med       Date:  2014-10-06       Impact factor: 10.057
  3 in total
  8 in total

1.  Investigation of the quantitative accuracy of low-dose amyloid and tau PET imaging.

Authors:  Ying-Hwey Nai; Shoichi Watanuki; Manabu Tashiro; Nobuyuki Okamura; Hiroshi Watabe
Journal:  Radiol Phys Technol       Date:  2018-10-16

2.  Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with 18F-fluorodeoxyglucose-positron emission tomography in stage IB cervical cancer.

Authors:  Alexander J Lin; Jason D Wright; Farrokh Dehdashti; Barry A Siegel; Stephanie Markovina; Julie Schwarz; Premal H Thaker; David G Mutch; Matthew A Powell; Perry W Grigsby
Journal:  Int J Gynecol Cancer       Date:  2019-08-30       Impact factor: 3.437

3.  Gallium-68-labeled fibroblast activation protein inhibitor PET in gastrointestinal cancer: insights into diagnosis and management.

Authors:  Chunxia Qin; Yangmeihui Song; Yongkang Gai; Weiwei Ruan; Qingyao Liu; Fang Liu; Danzha Zheng; Peng Zhang; Hongli Liu; Tao Zhang; Kaixiong Tao; Xiaoli Lan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-06-03       Impact factor: 10.057

4.  Difficulty in Distinguishing Pulmonary Arterial Intimal Sarcoma from Pulmonary Thromboembolism Using FDG PET/CT.

Authors:  Hirotaka Suto; Makiko Suto; Yumiko Inui; Atsuo Okamura
Journal:  In Vivo       Date:  2022 May-Jun       Impact factor: 2.406

5.  Prediction of Non-Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients with 18F-FDG PET Radiomics Based Machine Learning Classification.

Authors:  Roelof J Beukinga; Floris B Poelmann; Gursah Kats-Ugurlu; Alain R Viddeleer; Ronald Boellaard; Robbert J De Haas; John Th M Plukker; Jan Binne Hulshoff
Journal:  Diagnostics (Basel)       Date:  2022-04-24

Review 6.  Imaging for Target Delineation and Treatment Planning in Radiation Oncology: Current and Emerging Techniques.

Authors:  Sonja Stieb; Brigid McDonald; Mary Gronberg; Grete May Engeseth; Renjie He; Clifton David Fuller
Journal:  Hematol Oncol Clin North Am       Date:  2019-09-17       Impact factor: 3.722

Review 7.  Current State of Breast Cancer Diagnosis, Treatment, and Theranostics.

Authors:  Arya Bhushan; Andrea Gonsalves; Jyothi U Menon
Journal:  Pharmaceutics       Date:  2021-05-14       Impact factor: 6.321

8.  Nonspecific Uptake of 68Ga-Prostate-Specific Membrane Antigen in Diseases other than Prostate Malignancy on Positron Emission Tomography/Computed Tomography Imaging: A Pictorial Assay and Review of Literature.

Authors:  Dharmender Malik; Apurva Sood; Bhagwant Rai Mittal; Harmandeep Singh; Rajender Kumar Basher; Jaya Shukla; Anish Bhattacharya; Shrawan Kumar Singh
Journal:  Indian J Nucl Med       Date:  2018 Oct-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.